Daily Papers

We address two challenges of probabilistic topic modelling in order to better estimate the probability of a word in a given context, i.e., P(word|context): (1) No Language Structure in Context: Probabilistic topic models ignore word order by summarizing a given context as a "bag-of-word" and consequently the semantics of words in the context is lost. The LSTM-LM learns a vector-space representation of each word by accounting for word order in local collocation patterns and models complex characteristics of language (e.g., syntax and semantics), while the TM simultaneously learns a latent representation from the entire document and discovers the underlying thematic structure. We unite two complementary paradigms of learning the meaning of word occurrences by combining a TM (e.g., DocNADE) and a LM in a unified probabilistic framework, named as ctx-DocNADE. (2) Limited Context and/or Smaller training corpus of documents: In settings with a small number of word occurrences (i.e., lack of context) in short text or data sparsity in a corpus of few documents, the application of TMs is challenging. We address this challenge by incorporating external knowledge into neural autoregressive topic models via a language modelling approach: we use word embeddings as input of a LSTM-LM with the aim to improve the word-topic mapping on a smaller and/or short-text corpus. The proposed DocNADE extension is named as ctx-DocNADEe. We present novel neural autoregressive topic model variants coupled with neural LMs and embeddings priors that consistently outperform state-of-the-art generative TMs in terms of generalization (perplexity), interpretability (topic coherence) and applicability (retrieval and classification) over 6 long-text and 8 short-text datasets from diverse domains.

Adverse drug events (ADEs) significantly impact clinical research, causing many clinical trial failures. ADE prediction is key for developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel predictive modeling of ADEs in monopharmacy treatments. CT-ADE integrates data from 2,497 unique drugs, encompassing 168,984 drug-ADE pairs extracted from clinical trials, annotated with patient and contextual information, and comprehensive ADE concepts standardized across multiple levels of the MedDRA ontology. Preliminary analyses with large language models (LLMs) achieved F1-scores up to 55.90%. Models using patient and contextual information showed F1-score improvements of 21%-38% over models using only chemical structure data. Our results highlight the importance of target population and treatment regimens in the predictive modeling of ADEs, offering greater performance gains than LLM domain specialization and scaling. CT-ADE provides an essential tool for researchers aiming to leverage artificial intelligence and machine learning to enhance patient safety and minimize the impact of ADEs on pharmaceutical research and development. The dataset is publicly accessible at https://github.com/ds4dh/CT-ADE.

We develop an algorithm that can detect pneumonia from chest X-rays at a level exceeding practicing radiologists. Our algorithm, CheXNet, is a 121-layer convolutional neural network trained on ChestX-ray14, currently the largest publicly available chest X-ray dataset, containing over 100,000 frontal-view X-ray images with 14 diseases. Four practicing academic radiologists annotate a test set, on which we compare the performance of CheXNet to that of radiologists. We find that CheXNet exceeds average radiologist performance on the F1 metric. We extend CheXNet to detect all 14 diseases in ChestX-ray14 and achieve state of the art results on all 14 diseases.

Chest X-rays (CXRs) are the most frequently performed imaging test in clinical practice. Recent advances in the development of vision-language foundation models (FMs) give rise to the possibility of performing automated CXR interpretation, which can assist physicians with clinical decision-making and improve patient outcomes. However, developing FMs that can accurately interpret CXRs is challenging due to the (1) limited availability of large-scale vision-language datasets in the medical image domain, (2) lack of vision and language encoders that can capture the complexities of medical data, and (3) absence of evaluation frameworks for benchmarking the abilities of FMs on CXR interpretation. In this work, we address these challenges by first introducing CheXinstruct - a large-scale instruction-tuning dataset curated from 28 publicly-available datasets. We then present CheXagent - an instruction-tuned FM capable of analyzing and summarizing CXRs. To build CheXagent, we design a clinical large language model (LLM) for parsing radiology reports, a vision encoder for representing CXR images, and a network to bridge the vision and language modalities. Finally, we introduce CheXbench - a novel benchmark designed to systematically evaluate FMs across 8 clinically-relevant CXR interpretation tasks. Extensive quantitative evaluations and qualitative reviews with five expert radiologists demonstrate that CheXagent outperforms previously-developed general- and medical-domain FMs on CheXbench tasks. Furthermore, in an effort to improve model transparency, we perform a fairness evaluation across factors of sex, race and age to highlight potential performance disparities. Our project is at https://stanford-aimi.github.io/chexagent.html.